United States

Innovate Biopharmaceuticals Inc (INNT.OQ)

INNT.OQ on NASDAQ Stock Exchange Capital Market

22 Feb 2019
Change (% chg)

$-0.24 (-11.54%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Sandeep Laumas

49 2018 Executive Chairman of the Board

Jay Madan

52 2018 President, Chief Business Officer, Interim Principal Financial Officer, Interim Principal Accounting Officer and Director

Christopher Prior

65 2018 Chief Executive Officer, Director

June Almenoff

61 2018 Chief Operating Officer and Chief Medical Officer

Stephen Brownsell

2016 Executive Vice President